Art. 3 Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009…

Conditions for obtaining a certificate

In forcesince 6 May 2009cited 49×

A certificate shall be granted if, in the Member State in which the application referred to in Article 7 is submitted and at the date of that application:

(a)

the product is protected by a basic patent in force;

(b)

a valid authorisation to place the product on the market as a medicinal product has been granted in accordance with Directive 2001/83/EC or Directive 2001/82/EC, as appropriate;

(c)

the product has not already been the subject of a certificate;

(d)

the authorisation referred to in point (b) is the first authorisation to place the product on the market as a medicinal product.

The 10 that are cited most themselves, of 49.

  • Judgment of the Court (Fourth Chamber) of 24 November 2011. Medeva BV v Comptroller General of Patents, Designs and Trade Marks.Decision

    On those grounds, the Court (Fourth Chamber) hereby rules: 1. Article 3(a) of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal …

    24 Nov 2011 · 62010CJ0322

  • Judgment of the Court (Fourth Chamber) of 24 November 2011. Georgetown University and Others v Comptroller General of Patents, Designs and TDecision

    Article 3 of Regulation No 469/2009, entitled ‘Conditions for obtaining a certificate’, provides as follows: ‘A certificate shall be granted if, in the Member State in which the application referred to in Article 7 is submitted and …

    24 Nov 2011 · 62010CJ0422

  • Judgment of the Court (Eighth Chamber) of 15 January 2015. Arne Forsgren v Österreichisches Patentamt.Decision

    In that regard, it should be borne in mind that the grant of an SPC requires fulfilment of the four cumulative conditions set out in Article 3 of Regulation No 469/2009. That provision provides, in essence, that an SPC can be granted only …

    15 Jan 2015 · 62013CJ0631

  • Judgment of the Court (Fourth Chamber), 19 July 2012. Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents.Decisioninterprets

    This reference for a preliminary ruling relates to the interpretation of, first, Articles 3 and 13(1) of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection …

    19 Jul 2012 · 62011CJ0130

  • Order of the Court (Fourth Chamber) of 25 November 2011. University of Queensland and CSL Ltd v Comptroller General of Patents, Designs and Decision

    On those grounds, the Court (Fourth Chamber) hereby rules: 1. Article 3(a) of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal …

    25 Nov 2011 · 62010CO0630

  • Judgment of the Court (Third Chamber), 12 December 2013. Actavis Group PTC EHF and Actavis UK Ltd v Sanofi.Decision

    This request for a preliminary ruling concerns the interpretation of Article 3 of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal …

    12 Dec 2013 · 62012CJ0443

  • Order of the Court (Fourth Chamber) of 25 November 2011. Daiichi Sankyo Company v Comptroller General of Patents, Designs and Trade Marks.Decision

    This reference for a preliminary ruling concerns the interpretation of Article 3 of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal …

    25 Nov 2011 · 62011CO0006

  • Judgment of the Court (Grand Chamber) of 25 July 2018. Teva UK Ltd and Others v Gilead Sciences Inc.Decision

    On those grounds, the Court (Grand Chamber) hereby rules: Article 3(a) of Regulation No 469/2009 of the European Parliament and of the Council of 6 May 2009, concerning the supplementary protection certificate for medicinal products, must …

    25 Jul 2018 · 62017CJ0121

  • Judgment of the Court (Eighth Chamber) of 12 March 2015. Actavis Group PTC EHF and Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. KDecision

    This request for a preliminary ruling concerns the interpretation of Articles 3 and 13 of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for …

    12 Mar 2015 · 62013CJ0577

  • Judgment of the Court (Third Chamber), 12 December 2013. Eli Lilly and Company Ltd v Human Genome Sciences Inc.Decision

    On those grounds, the Court (Third Chamber) hereby rules: Article 3(a) of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products …

    12 Dec 2013 · 62012CJ0493